mIDH1-mutated AML: ivosidenib in clinical practice

This Servier arranged webinar is for hematologists. The agenda for the webinar is: 12:00-12:05 – Introduction by Erik Holgén, Product Manager, Servier 12:05-12:30 – Prof. Dr. Michael Heuser - Will […]

MNSCT 2024 Meeting

MNSCT 2024 Meeting  Date: 21 November 2024 Venue: Grand Hotel, Lund, Sweden or online Registration: https://mkon.nu/mnsct_2024/registration Program 12:00-12:55   Lunch, registration starts at 11.45 13:00-13:05   Welcome/Introduction  (Assoc. Prof. Andreas Björklund, Stockholm, Assoc. Prof. Jörg Cammenga, Lund) Session […]

Why a Nordic AML Group?

Recognizeable systems in Nordic countries, similar treatment traditions, one working market.

Unmet need to improve AML therapy through research and clinical trials.

Sign up for our newsletter

This field is for validation purposes and should be left unchanged.
Name(Required)
Email(Required)
Privacy(Required)